QiQi,
However you cut it re: Phase 1b, Phase 2 etc, what's not in dispute is that as of November 2020, only 14 patients have been dosed and the company has confirmed that it doesn't expect to be able to conclude the scaled-down 34 person trial (at which point still only 17 patients will have been dosed with HER-Vaxx) until end-2021.
The rest of your comments suggest that we're in violent agreement. That's the point I'm making: IMU is a speculative company in which shareholders hold a lottery ticket. And there are several shareholders on this site who seem to want to moonlight as clairvoyants ...
Re:Re:Charts:Imugene, page-40
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.5¢ |
Change
0.001(1.19%) |
Mkt cap ! $622.1M | |||
| Open | High | Low | Value | Volume |
| 8.3¢ | 8.6¢ | 8.2¢ | $1.062M | 12.66M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 495709 | 8.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.5¢ | 919740 | 6 |
View Market Depth
| Last trade - 16.10pm 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
8.4¢ |
Change
0.001 ( 0.84 %) |
||||
| Open | High | Low | Volume | ||
| 8.4¢ | 8.6¢ | 8.2¢ | 6843386 | ||
| Last updated 15.59pm 02/05/2024 ? | |||||
| IMU (ASX) Chart |